BSE filing, NSE: BABA. Summary written from the filing by ALFA Finder's alert engine.
Baba Arts Ltd: key numbers
- Share price
- ₹21.25
- Market cap
- ₹111.6 Cr
- Revenue (annual)
- ₹14.95 Cr
- Net profit (annual)
- ₹0.65 Cr
- P/E (TTM)
- 245.9×Sector 28.6×
- Promoter holding
- 74.68%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Baba Arts Ltd
All →Baba Arts Q2 FY27 Results: Net Profit ₹0.2 Cr, Down 50.0% YoY
Baba Arts Ltd reported net profit of ₹0.2 Cr (-50.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.2 Cr · -50.0% YoY
Baba Arts Other Announcement
Baba Arts Ltd disclosed KMPs authorised for Reg 30(5) LODR disclosures. This is a routine compliance intimation with no business or financial impact.
Baba Arts Annual General Meeting
Baba Arts Limited issued a corrigendum to the notice of its 27th Annual General Meeting scheduled for November 3, 2026, correcting typographical errors.
Baba Arts Board Meeting Date
Baba Arts Ltd notified BSE that its Board will meet on 26 October 2026 to approve un-audited financial results for Q1 and H1 FY27. The trading window stays closed until 28 October 2026.
Baba Arts Annual Report
Baba Arts Limited has released its Annual Report for the financial year 2025-26, containing the notice for the 27th Annual General Meeting to be held.
Baba Arts Annual General Meeting
Baba Arts Ltd has submitted the notice of its 27th Annual General Meeting scheduled for November 3, 2026, and its Annual Report for FY 2025-26.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.